SGMS1 and metastatic melanoma: Furthermore, downregulation of SMS1 hasbeen reported in patients with metastatic melanoma, whereit is associated with worse prognosis due to an imbalancebetween sphingomyelin and glucosylceramide levels (Bilalet al., 2019).